anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

131,281-131,340 of 319,975

filter-aware
124
The slide uses a combination of a bar chart and a financial table to highlight the discrepancy in Capex spending patterns.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
125
The slide highlights a potential red flag in capital allocation strategy.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
126
The slide uses direct quotes from earnings call transcripts to point out inconsistencies in financial reporting.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
127
The slide uses direct quotes and SEC filing excerpts to demonstrate a pattern of inconsistent financial reporting by the CFO.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
128
The slide uses direct quotes from an earnings call transcript to demonstrate the CFO's contradictory statements about where the $90-100MM CapEx is being spent.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
129
The slide uses a 'villain' framing by criticizing both the company's lack of disclosure and the sell-side analysts' failure to probe.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
130
The slide uses a rhetorical question to frame the discrepancy in capex as a potential red flag.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
131
The slide uses a visual comparison (red arrow) to highlight that the 'factory' imagery is just a rendering.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
132
The slide uses a visual 'gotcha' to undermine corporate credibility regarding capital expenditure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
133
Uses visual evidence to highlight a discrepancy between reported spending and physical reality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
134
Uses field investigation to debunk corporate narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
135
The slide uses visual evidence to undermine management's narrative regarding facility activity.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
136
The slide uses a table from a 10K filing and a direct quote to expose a discrepancy in corporate messaging.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
137
The slide uses a quote from the CEO to establish a timeline and operational status that may be contrasted with other data in the deck.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
138
The slide uses screenshots of job listings to debunk the company's narrative about its Oregon facility.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
139
The slide uses a 'kabuki theater' metaphor to describe the company's operational claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
140
Uses transcript excerpts to demonstrate management's shift in tone and evasion of specific revenue questions.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
141
Uses direct quotes to undermine company narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
142
Uses a combination of earnings call transcript excerpts and a table from a 10K filing to point out the discrepancy.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
143
The slide uses a combination of aggressive narrative text and visual evidence (screenshots of conceptual diagrams) to undermine the company's credibility.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
144
The slide uses a chronological sequence of quotes to highlight the lack of progress and shifting narratives.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
145
Uses LinkedIn search results as a proxy for employee headcount and expertise to challenge corporate financial disclosures.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
146
The slide is essentially a single, long, aggressive thesis statement.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
147
The slide uses a Q&A format to provide evidence of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
148
The slide uses a Q&A format to expose a contradiction between company marketing and customer experience.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
149
The slide uses a Q&A format to highlight negative feedback from a customer.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
150
Uses a Q&A format to highlight a negative expert opinion on Twist's competitive positioning.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
151
The slide uses Q&A format to highlight negative sentiment from a large customer.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
152
The slide uses a direct quote from a Novartis scientist to undermine Twist's 'high-throughput' value proposition.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
153
The slide uses direct quotes from a customer to frame Twist as a commodity player struggling against dominant incumbents.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
154
The slide uses a Q&A format to validate the thesis of customer churn due to operational inefficiency.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
155
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
156
The slide uses a Q&A format and direct quotes to build a case against the subject company's operational quality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
157
The slide uses a Q&A format to highlight reputational risks and quality concerns regarding Twist Bioscience.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
158
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
159
Uses direct quotes to undermine the company's technical capabilities.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
160
The slide uses a quote to undermine the company's technical capabilities.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
161
The slide uses a Q&A format to expose a gap between Twist's marketing claims and customer reality regarding oligo length capabilities.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
162
The slide uses a Q&A transcript format to highlight negative sentiment from a major customer.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
163
The slide uses direct quotes from a major genomics center and an ex-IDT manager to build a case against Twist's product reliability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
164
The slide uses direct quotes from a customer to undermine the company's quality reputation.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
165
The slide uses a Q&A format to validate the thesis that Twist is losing market share due to quality/consistency issues.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
166
The slide uses direct quotes from an IDT ex-regional sales manager to undermine the target company's marketing claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
167
The slide uses a Q&A format to highlight operational failures.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
168
The slide uses highlighted text to emphasize key arguments regarding Twist's perceived lack of technical innovation and reliance on unsustainable pricing.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
169
The slide uses direct quotes from a competitor to undermine the target company's credibility.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
170
The slide uses direct quotes from former employees and competitors to undermine the company's value proposition.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
171
Twist Bioscience (TWST)Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
172
The slide uses a Q&A transcript format to build a case against the company's competitive moat.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
173
The slide uses Q&A format to present expert testimony regarding market commoditization and competitive threats.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
174
The slide uses expert testimony to undermine the company's moat.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
175
The slide uses quotes from former employees to undermine the company's growth narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
176
The slide uses direct quotes from a competitor to frame the target company's business model as unsustainable.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
177
The slide uses Q&A transcripts to undermine the competitive moat of the subject company (Twist).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
178
The slide uses a Q&A format to frame the expert's testimony as a critique of Twist's business model.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
179
The slide uses a Q&A format to highlight negative sentiment from a key customer.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
180
The slide uses a Q&A format to validate the thesis that Twist is a 'race to the bottom' competitor.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
181
The slide uses a direct quote from an expert consultation to undermine the target company's (Twist) business model and sustainability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
182
The slide uses direct quotes from a former competitor employee to frame Twist's strategy as low-quality/low-cost vs. the industry standard of quality-focused value propositions.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
183
The slide acts as a narrative transition, framing the upcoming section as a critique of the company's growth sustainability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit